Detalhe da pesquisa
1.
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).
Nat Immunol
; 24(10): 1616-1627, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37667052
2.
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
Cell
; 183(1): 158-168.e14, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32979941
3.
Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination.
Immunity
; 55(9): 1732-1746.e5, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35961317
4.
Author Correction: SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC).
Nat Immunol
; 24(10): 1778, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37723351
5.
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.
N Engl J Med
; 389(1): 22-32, 2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345876
6.
Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional Anomalies.
J Immunol
; 212(3): 389-396, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38117799
7.
Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age.
Proc Natl Acad Sci U S A
; 120(12): e2220320120, 2023 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36917669
8.
Distinct roles of vaccine-induced SARS-CoV-2-specific neutralizing antibodies and T cells in protection and disease.
Mol Ther
; 32(2): 540-555, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38213030
9.
Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19.
J Infect Dis
; 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421006
10.
Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase 3 randomized trial.
J Hepatol
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38734383
11.
The cascade of care for patients with chronic hepatitis delta in Southern Stockholm, Sweden for the past 30 years.
Liver Int
; 44(1): 228-240, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904316
12.
Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients.
Liver Int
; 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38560775
13.
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity.
Proc Natl Acad Sci U S A
; 118(6)2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33479167
14.
High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19.
Proc Natl Acad Sci U S A
; 118(40)2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34548411
15.
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta.
J Hepatol
; 79(3): 657-665, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37120031
16.
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
J Hepatol
; 79(2): 576-580, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37030400
17.
SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants.
J Clin Immunol
; 43(6): 1075-1082, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37058198
18.
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality.
N Engl J Med
; 382(11): 1018-1028, 2020 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32160663
19.
COVID-19-specific metabolic imprint yields insights into multiorgan system perturbations.
Eur J Immunol
; 52(3): 503-510, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34837225
20.
Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia.
Respir Res
; 24(1): 62, 2023 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36829233